2 Growth Stocks to Buy Hand Over Fist in April
These healthcare companies' target markets substantially overlap.
Stay updated with breaking news from Dexcom One. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
These healthcare companies' target markets substantially overlap.
Dexcom's Q4 2023 performance, reporting $1.03 billion sales, $256.3 million profits, and beating estimates. Dexcom projects $4.15-$4.35 billion in 2024 revenues. William Blair affirms Outperform rating.
Dexcom (Nasdaq:DXCM) announced today that it launched its latest continuous glucose monitor (CGM) system, the Dexcom ONE+.
Dexcom (Nasdaq:DXCM) recently announced the availability of its Dexcom One real-time continuous glucose monitor (CGM) in France.
For people with diabetes treated with insulin, Dexcom rtCGM is associated with significant improvements over patients’ lifetimes and is likely to be cost-saving to the NHS ... | May 3, 2023